ACROBiosystems has developed novel hydrogel-free human iPSC-derived, assay ready, cardiac and cerebral organoid systems. These systems are now commercially available. Both cerebral and cardiac ...

Through this collaboration, InSphero will be granted exclusive global rights for the commercialization of Genome Biologics' 3D Cardiac Organoid Platform. This will lead to the use of accurate ...

While treatments for cancer and heart disease have advanced in leaps and bounds, psychiatry continues to use the drugs that ...

Yoo Jong-man seeks approval for mini organoid treatments in South Korea this year Researcher pushes for novel therapies utilizing advanced mini organoid technology in Korea ...

cell lines that can be differentiated into organoid models recapitulating disease-associated phenotypes. ASO delivery and efficacy was first optimized by targeting cardiac troponin T in cardiac ...

Q4 2024 Earnings Call Transcript March 12, 2025 Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $0.06, ...

The study also explored the impact on brain function using lab-grown brain organoid models and found that metabolic imbalances affect neuronal activity. "By using the cutting-edge 3D brain ...

The Cambridge Festival is returning from March 19 to April 4 with a series of events that bring together cutting-edge health ...